Founders Capital Management (Texas)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,000
Closed -$27.1K – 271
2026
Q2
$27.1K Hold
2,000
– – 0.01% 226
2026
Q1
$12K Hold
2,000
– – 0.01% 303
2025
Q4
$14.3K Buy
+2,000
New +$15.8K 0.01% 278
2023
Q2
– Sell
-125
Closed -$3K – 402
2023
Q1
$3K Hold
125
– – ﹤0.01% 358
2022
Q4
$3K Hold
125
– – ﹤0.01% 352
2022
Q3
$3K Sell
125
-50
-29% -$1.51K ﹤0.01% 360
2022
Q2
$6K Buy
+175
New +$6.13K ﹤0.01% 356
2021
Q3
– Sell
-2,722
Closed -$82K – 325
2021
Q2
$82K Buy
+2,722
New +$89.6K 0.05% 91

Other funds holding OGN

Founders Capital Management (Texas)'s OGN Position: Q3 2026 in Review

Founders Capital Management (Texas) sold out of Organon & Co (OGN) in Q3 2026, closing a stake of 2,000 shares — an estimated $27.1K sold.

Founders Capital Management (Texas) first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $82K in Q2 2021. 37 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Founders Capital Management (Texas) reported no remaining Organon & Co position as of Q3 2026 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 2,000 Organon & Co shares in Q3 2026, an estimated $27.1K.
  • Founders Capital Management (Texas) first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Founders Capital Management (Texas)'s Organon & Co position peaked at $82K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q3 2026, filed 13 Oct 2026.